Cours Bausch Health Companies Inc Nyse
Actions
CA91911K1021
Produits pharmaceutiques
CA 2024 * | 9,4 Md 8,52 Md | CA 2025 * | 9,67 Md 8,76 Md | Capitalisation | 2,62 Md 2,37 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 148 M 134 M | Résultat net 2025 * | 389 M 353 M | VE / CA 2024 * | 2,45 x |
Dette nette 2024 * | 20,44 Md 18,53 Md | Dette nette 2025 * | 19,09 Md 17,3 Md | VE / CA 2025 * | 2,25 x |
PER 2024 * |
21,1
x | PER 2025 * |
6,76
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,62% |
Dernier transcript sur Bausch Health Companies Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24/05/22 |
Chief Operating Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01/08/08 |
John Paulson
CHM | Chairman | 68 | 01/06/17 |
Steven Miller
BRD | Director/Board Member | 35 | 17/03/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+31,06% | 682 Md | |
+30,35% | 586 Md | |
-3,42% | 364 Md | |
+18,02% | 327 Md | |
+4,27% | 285 Md | |
+15,53% | 240 Md | |
+10,16% | 209 Md | |
-8,14% | 203 Md | |
+8,12% | 165 Md |